SCI Pharmtech financials at a glance

Year Year 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Rev. Revenue
NT$457.88M NT$454.11M NT$514.94M NT$802.86M NT$945.42M NT$905.74M NT$994.68M NT$1.04B NT$1.26B NT$1.29B NT$1.49B NT$1.81B NT$1.90B NT$1.30B NT$1.94B NT$2.36B NT$2.69B NT$864.22M NT$899.74M NT$1.20B NT$0.00M
GM % Gross Margin %
25.78% 22.12% 21.29% 31.48% 32.38% 36.59% 33.07% 29.60% 31.60% 30.71% 32.13% 36.18% 41.54% 30.41% 38.61% 39.72% 47.39% 24.08% 32.36% 29.09% 0.00%
OM Operating Margin
13.50% 10.05% 8.24% 21.12% 20.66% 23.70% 21.38% 17.95% 20.00% 15.92% 19.80% 24.29% 27.14% 18.03% 26.58% 29.59% 39.10% 8.52% 13.22% 13.31% 0.00%
EPS Earnings Per Share
NT$2.12 NT$2.24 NT$2.28 NT$2.71 NT$1.71 NT$2.54 NT$3.54 NT$3.87 NT$1.77 NT$4.13 NT$5.33 NT$3.36 NT$0.52 NT$2.87 NT$2.87 NT$0.00
Div. Dividends
NT$0.00 NT$0.00 NT$0.00 NT$0.00 NT$0.00 NT$0.00 NT$0.00 NT$0.00 NT$0.00 NT$0.00 NT$2.30 NT$0.00 NT$0.00 NT$1.59 NT$3.11 NT$4.30 NT$0.37 NT$0.43 NT$0.22 NT$0.22 NT$0.00
PR % Payout Ratio %
0 0 0 0 0 0 0 0 0 0 90.55% 0 0 89.83% 75.30% 80.68% 11.01% 82.69% 7.67% 7.67% 0
Sha. Shares
52.66m 52.75m 52.75m 52.75m 53.34m 54.14m 55.19m 55.75m 55.88m 68.99m 69.69m 75.12m 79.49m 79.49m 79.49m 77.56m 79.49m 79.49m 95.38m 0m 119.51m
OCF Operating Cash Flow
NT$78.58M NT$159.64M NT$131.62M NT$167.53M NT$240.83M NT$316.96M NT$218.96M NT$249.67M NT$387.53M NT$238.57M NT$358.77M NT$663.24M NT$502.11M NT$281.65M NT$480.18M NT$791.60M NT$971.53M NT$280.28M NT$296.57M NT$215.77M NT$0.00M
FCF Free Cash Flow
NT$41.07M NT$97.98M NT$-30.38M NT$0.32M NT$102.71M NT$145.99M NT$28.80M NT$101.96M NT$206.63M NT$-534.46M NT$-10.38M NT$511.40M NT$378.71M NT$135.39M NT$333.35M NT$592.09M NT$753.83M NT$-494.70M NT$-871.02M NT$-813.59M NT$0.00M
FCFS Free Cash Flow Per Share
NT$0.78 NT$1.86 NT$-0.58 NT$0.01 NT$1.92 NT$2.50 NT$0.52 NT$1.84 NT$3.70 NT$-7.75 NT$-1.40 NT$6.17 NT$4.88 NT$1.69 NT$4.00 NT$7.39 NT$7.90 NT$-5.19 NT$-8.12 NT$-7.44 NT$0.00